VAALCO ENERGY INC (EGY)       4.53  -0.02 (-0.44%)

4.53  -0.02 (-0.44%)

US91851C2017 - Common Stock - After market: 4.53 0 (0%)


Fundamental Rating

6

Taking everything into account, EGY scores 6 out of 10 in our fundamental rating. EGY was compared to 386 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and the financial health of EGY get a neutral evaluation. Nothing too spectacular is happening here. EGY is evaluated to be cheap and growing strongly. This does not happen too often!




Profitability

Profitability Rating

4

EGY's Return On Assets of 17.35% is amongst the best of the industry. EGY does better than the industry average Return On Assets of 13.05%.
EGY has a Return On Equity of 39.44%. This is better than the industry average of 28.11%.

EGY has a Piotroski-F score of 6.00. This indicates an average health and profitability for EGY.
EGY's Profit Margin of 21.81% is worse than the rest of the industry. The industry average Profit Margin is 26.04%.
VS Industry

ROA (17.35%) VS Industry: 65% outperformed.

0.06
1,708.00

ROE (39.44%) VS Industry: 70% outperformed.

0.30
19,161.80

Profit Margin (21.81%) VS Industry: 40% outperformed.

0.07
334.14

Valuation

Valuation Rating

8

With a Price/Earnings Ratio of 2.89, the valuation of EGY can be described as very cheap.
EGY's Price/Earning Ratio is rather cheap when compared to the industry average which is at 5.76. EGY is also cheaper than 84% of the companies in the same industry.
With a Forward Price/Earnings Ratio of 2.43, the valuation of EGY can be described as cheap.
EGY's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the Enterprise Value to EBITDA ratio of EGY to the average industry ratio of 3.72, EGY is valued rather cheaply.
When comparing the current price to the book value of EGY, we can conclude it is valued correctly. It is trading at 2.83 times its book value.
When comparing the price book ratio of EGY to the average industry price book ratio of 1.45, EGY is valued more expensive than its industry peers.
VS Industry

Price/Earnings (2.89) VS Industry: 84% outperformed.

4,812.50
0.01

Price/Book (2.83) VS Industry: 22% outperformed.

4,069.87
0.04

Enterprise Value/ EBITDA (2.05) VS Industry: 80% outperformed.

240.87
0.08

Growth

Growth Rating

8

EGY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 336.11%, which is quite impressive.
Based on estimates for the next 5 years, EGY will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.65% on average per year.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
Looking at the last year, EGY shows a very strong growth in Revenue. The Revenue has grown by 102.33%.

EGY shows a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 27.19% yearly.
The Revenue is expected to grow by 29.78% on average over the next 5 years. This is a very strong growth
EGY shows a decrease in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -5.07% yearly.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A -5.07% 336.11% -0.46% 33.92% 8.08% 11.65%
Revenue27.19% 23.81% 102.33% 99.45% 69.91% 32.68% 29.78%

Health

Health Rating

5

The Debt to Equity ratio of EGY is way better than the industry averages.
An Altman-Z score of 4.06 indicates that EGY is not in any danger for bankruptcy at the moment.
EGY is in better financial health than average in its industry. Its Altman-Z score is much better than the industry average of 2.00.
The Quick Ratio is in line with the industry averages, which is at 1.02.

EGY has a Piotroski-F score of 6.00. This indicates an average health and profitability for EGY.
EGY has a Current Ratio of 0.86. This is a bad value and indicates that EGY is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Current Ratio of EGY to the average industry Current Ratio of 1.17, EGY is less able to pay its short term obligations than its industry peers.
EGY has a Quick Ratio of 0.86. This is a bad value and indicates that EGY is not financially healthy enough and could expect problems in meeting its short term obligations.
VS Industry

Debt/Equity (0.01) VS Industry: 74% outperformed.

78.08
0.00

Quick Ratio (0.83) VS Industry: 41% outperformed.

0.00
279.52

Current Ratio (0.86) VS Industry: 36% outperformed.

0.00
279.52

Altman-Z (4.06) VS Industry: 76% outperformed.

-283,883.15
908.88

Dividend

Dividend Rating

4

With a Yearly Dividend Yield of 6.01%, EGY is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.60, EGY pays a better dividend.

EGY's Dividend Yield is comparable with the industry average which is at 5.67.
EGY does not have a reliable dividend history as it only pays dividend since a couple or years.
VS Industry

Dividend Yield (6.01%) VS Industry: 52% outperformed.

0.32
64.51

VAALCO ENERGY INC4.53

NYSE:EGY (3/31/2023, 3:21:25 PM)-0.02 (-0.44%)

After market: 4.53 0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-08 2023-03-08
Earnings (Next)05-01 2023-05-01
Inst Owners51.83%
Inst Owner Change63.13%
Ins Owners1.03%
Ins Owner Change-2.97%
Market Cap490.94M
Analysts83.33
Price Target0.11 (-97.57%)
Dividend
Industry RankSector Rank
Dividend Yield 6.01%
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date03-23 2023-03-23 (0.0625)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)-28.66%
Min EPS beat(2)-31.93%
Max EPS beat(2)-25.38%
EPS beat(4)2
Avg EPS beat(4)37.16%
Min EPS beat(4)-31.93%
Max EPS beat(4)187.13%
Revenue beat(2)2
Avg Revenue beat(2)13.16%
Min Revenue beat(2)2.61%
Max Revenue beat(2)23.72%
Revenue beat(4)4
Avg Revenue beat(4)17.02%
Min Revenue beat(4)2.61%
Max Revenue beat(4)23.72%
PT rev (1m)-4.05%
PT rev (3m)-3.97%
EPS NQ rev (1m)-9.23%
EPS NQ rev (3m)-9.23%
EPS NY rev (1m)-12.39%
EPS NY rev (3m)-12.39%
Revenue NQ rev (1m)-6.45%
Revenue NQ rev (3m)-6.45%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE 2.89
Fwd PE 2.43
P/S 1.56
P/FCF 23.22
P/OCF 3.69
P/B 2.83
P/tB 2.83
EV/EBITDA 2.05
EPS(TTM)1.57
EY34.66%
EPS(NY)1.87
Fwd EY41.17%
FCF(TTM)0.2
FCFY4.31%
OCF(TTM)1.23
OCFY27.11%
SpS2.9
BVpS1.6
TBVpS1.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.35%
ROE 39.44%
ROIC 57.04%
ROICexc 78.7%
ROICexgc 78.7%
OM 57.87%
PM 21.81%
GM 75.84%
ROICexgc(3y)23.62%
ROICexcg growth 3Y2.87%
ROICexcg growth 5YN/A
ROICexc(3y)23.62%
ROICexc growth 3Y2.87%
ROICexc growth 5YN/A
OM growth 3Y-6.69%
OM growth 5YN/A
PM growth 3Y-23.68%
PM growth 5YN/A
GM growth 3Y2.36%
GM growth 5Y12.18%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.07
Debt/EBITDA 0.01
Cap/Depr 431.27%
Profit Quality 30.87%
Current Ratio 0.86
Quick Ratio 0.83
Altman-Z 4.06
F-Score6
WACC10.56%
ROIC/WACC7.45
Cap/Depr(3y)196.36%
Cap/Depr(5y)173.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y336.11%
EPS 3Y-5.07%
EPS 5YN/A
EPS growth Q2Q-35.29%
EPS Next Y-0.46%
EPS Next 2Y33.92%
EPS Next 3Y8.08%
EPS Next 5Y11.65%
Revenue growth 1Y102.33%
Revenue growth 3Y23.81%
Revenue growth 5Y27.19%
Revenue growth Q2Q39.71%
Revenue Next Year99.45%
Revenue Next 2Y69.91%
Revenue Next 3Y32.68%
Revenue Next 5Y29.78%
EBIT growth 1Y271.31%
EBIT growth 3Y15.53%
EBIT growth 5YN/A
EBIT Next Year212.57%
EBIT Next 3Y77.22%
EBIT Next 5Y24.19%
FCF growth 1Y266.48%
FCF growth 3Y-21.78%
FCF growth 5YN/A
OCF growth 1Y706.64%
OCF growth 3Y10.45%
OCF growth 5YN/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA